Peter Osin

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

Isaac García-Murillas, Gaia Schiavon, Britta Weigelt et al. · Science Translational Medicine · 2015 · 1.1K citations

Medicine, Molecular Genetics, Oncology +17

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Sunil R. Lakhani, Marc J. van de Vijver, Jocelyne Jacquemier et al. · Journal of Clinical Oncology · 2002 · 827 citations

Medicine, Oncology, Pathology +17

Analysis of <i>ESR1</i> mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

Gaia Schiavon, Sarah Hrebien, Isaac García-Murillas et al. · Science Translational Medicine · 2015 · 564 citations · Full text

Medicine, Molecular Biology, Oncology +14

Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene

Stephen M. Edwards, Zsofia Kote‐Jarai, Rifat Hamoudi et al. · The American Journal of Human Genetics · 2003 · 365 citations · Full text

Medicine, Genetics, Oncology +12

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

Mónica Arnedos, Ashutosh Nerurkar, Peter Osin et al. · Annals of Oncology · 2009 · 181 citations · Full text

Medicine, Oncology, Pathology +14